Safety of Cardiac Pacemakers in 1.5T Tesla MRI

University Hospital Bonn (UKB)

Status: Completed

Conditions: Heart Diseases

Treatments: Device: Magnetic resonance imaging

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00336011

186/02

Details and patient eligibility

About

To evaluate short-term and long-term effects by MR imaging on the technical and functional status of Medtronic pacemakers.

Full description

The presence of a cardiac pacemaker (PM) is currently considered an absolute contraindication to MR imaging, and most patients with PM are excluded from having MRI. In 2002 there were approximately 2.4 million patients in the US with cardiac PM, and this number is growing by 80,000 annually. A previous study has shown that MRI is indicated in 17% of all patients with pacemakers within 12 months of device placement 1, demonstrating the need for a practical and safe approach for performing MRI on PM patients.

The aim of this study is to develop a strategy for safe performance of MR imaging at 1.5T, which included exclusion of pacemaker dependent patients and those requiring imaging of the thorax, restriction of specific absorption rate (SAR) values to minimize the risk of lead heating, and PM reprogramming to avoid interference from time varying gradient fields. The safety of this approach is then evaluated in a large group of PM patients including assessment of potential myocardial thermal injury by measuring serum troponin I and pacing capture thresholds, and performing a 3-month follow-up to evaluate long-term effects.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Urgent need for an MRI examination

• Presence of a Medtronic PM system manufactured between 1993 and 2004

• Stable pacemaker physical parameters

  • Battery voltage > 2.7 V
  • Battery impedance < 2000 Ohm
  • Battery estimated remaining lifetime > 6 months
  • Lead impedances 200-2000 Ohm

• Stable pacing parameters

  • Pacing capture threshold <2.5V at a pulse duration of 0.4ms
  • Sensing > 5mV

• Minimum 3 months since pacemaker and lead implantation

Exclusion criteria

• PM system manufacturer other than Medtronic

• History of ventricular tachycardia (VT) or ventricular fibrillation

• Unstable angina

• Myocardial infarction within the previous 3 months

• Cardiothoracic surgery within the previous 3 months

• Complete atrioventricular block

• Absolute pacemaker dependence

  • Heart rate < 40 bpm or
  • Heart rate < 60 bpm producing neurological symptoms

• Presence of an abdominal pacemaker with lead length > 70 cm

• Presence of MRI incompatible bioimplants or other MRI incompatible materials

• Request for an MR examination of the chest, including the heart, breasts and thoracic spine